Meeting of the National Vaccine Advisory Committee, 3268 [2012-1228]
Download as PDF
3268
Federal Register / Vol. 77, No. 14 / Monday, January 23, 2012 / Notices
referenced above, email your request,
including your address, phone number,
OMB number, and OS document
identifier, to
Sherette.funncoleman@hhs.gov, or call
the Reports Clearance Office on (202)
690–5683. Send written comments and
recommendations for the proposed
information collections within 30 days
of this notice directly to the OS OMB
Desk Officer; faxed to OMB at (202)
395–5806.
Proposed Project: Protection of
Human Subjects: Assurance
Identification/IRB Certification/
Declaration of Exemption Form
Extension—OMB No. 0990–0263—
Office for Human Research Protections.
Abstract: The Federal Policy for the
Protection of Human Subjects, known as
the Common Rule, requires that before
engaging in non-exempt human subjects
research that is conducted or supported
by a Common Rule department or
agency, each institution must: (1) Hold
an applicable assurance of compliance
[Section 103(a)]; and (2) certify to the
awarding department or agency that the
application or proposal for research has
been reviewed and approved by an IRB
designated in the assurance [Sections
103(b) and (f)]. The Office for Human
Research Protections is requesting a
three-year extension of the Protection of
Human Subjects: Assurance
Identification/IRB Certification/
Declaration of Exemption Form. That
form is designed to promote uniformity
among departments and agencies, and to
help ensure common means of
ascertaining institutional review board
certifications and other reporting
requirements relating to the protection
of human subjects in research.
Respondents are institutions engaged in
research involving human subjects
where the research is supported by
HHS. Institutional use of the form is
also relied upon by other federal
departments and agencies that have
codified or follow the Federal Policy for
the Protection of Human Subjects
(Common Rule). There are an estimated
total of 25,000 human research studies
supported each year, an average of 2
certifications per institution and an
estimated one-half hour per
certification, for a total burden of 12,000
hours. Data is collected as needed.
ESTIMATED ANNUALIZED BURDEN IN HOURS FOR IRB CERTIFICATION BURDEN
Form name
Number of
respondents
Number of
responses per
respondent
Hours per
response
Response
burden
hours
Protection of Human Subjects: Assurance Identification/IRB Certification/
Declaration of Exemption .............................................................................
12,000
2
30/60
12,000
Keith A. Tucker,
Office of the Secretary, Paperwork Reduction
Act Clearance Officer.
[FR Doc. 2012–1188 Filed 1–20–12; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Vaccine
Advisory Committee
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice of meeting.
AGENCY:
As stipulated by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the National Vaccine Advisory
Committee (NVAC) will hold a meeting.
The meeting is open to the public.
Preregistration is required for both
public attendance and comment.
Individuals who wish to attend the
meeting and/or participate in the public
comment session should register at
https://www.hhs.gov/nvpo/nvac, email
nvpo@hhs.gov or call (202) 690–5566
and provide name, organization, and
email address.
DATES: The meeting will be held on
February 7–8, 2012. The meeting times
TKELLEY on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
19:12 Jan 20, 2012
Jkt 226001
and agenda will be posted on the NVAC
Web site at https://www.hhs.gov/nvpo/
nvac as soon they become available.
ADDRESSES: The meeting will be held at
the U.S. Department of Health and
Human Services, Hubert H. Humphrey
Building, Room 800, 200 Independence
Avenue SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: The
National Vaccine Program Office, U.S.
Department of Health and Human
Services, Room 715–H, Hubert H.
Humphrey Building, 200 Independence
Avenue SW., Washington, DC 20201.
Phone: (202) 690–5566; Fax: (202) 690–
4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to Section 2101 of the Public Health
Service Act (42 U.S.C. 300aa–1), the
Secretary of Health and Human Services
was mandated to establish the National
Vaccine Program to achieve optimal
prevention of human infectious diseases
through immunization and to achieve
optimal prevention against adverse
reactions to vaccines. The National
Vaccine Advisory Committee was
established to provide advice and make
recommendations to the Director of the
National Vaccine Program on matters
related to the Program’s responsibilities.
The Assistant Secretary for Health
serves as Director of the National
Vaccine Program.
The topics to be discussed at the
NVAC meeting will include seasonal
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
influenza, implementation of the
National Vaccine Plan, and vaccine
safety. The meeting agenda will be
posted on the NVAC Web site: https://
www.hhs.gov/nvpo/nvac prior to the
meeting.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
National Vaccine Program Office at the
address/phone listed above at least one
week prior to the meeting. Members of
the public will have the opportunity to
provide comments at the NVAC
meeting, limited to five minutes per
speaker, during the public comment
periods on the agenda. Individuals who
would like to submit written statements
should email or fax their comments to
the National Vaccine Program Office at
least five business days prior to the
meeting.
Dated: January 17, 2012.
Mark Grabowsky,
Deputy Director, National Vaccine Program
Office, Alternate Designated Federal Officer,
National Vaccine Advisory Committee.
[FR Doc. 2012–1228 Filed 1–20–12; 8:45 am]
BILLING CODE 4150–44–P
E:\FR\FM\23JAN1.SGM
23JAN1
Agencies
[Federal Register Volume 77, Number 14 (Monday, January 23, 2012)]
[Notices]
[Page 3268]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-1228]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the National Vaccine Advisory Committee
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) will hold a
meeting. The meeting is open to the public. Preregistration is required
for both public attendance and comment. Individuals who wish to attend
the meeting and/or participate in the public comment session should
register at https://www.hhs.gov/nvpo/nvac, email nvpo@hhs.gov or call
(202) 690-5566 and provide name, organization, and email address.
DATES: The meeting will be held on February 7-8, 2012. The meeting
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon they become available.
ADDRESSES: The meeting will be held at the U.S. Department of Health
and Human Services, Hubert H. Humphrey Building, Room 800, 200
Independence Avenue SW., Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: The National Vaccine Program Office,
U.S. Department of Health and Human Services, Room 715-H, Hubert H.
Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201.
Phone: (202) 690-5566; Fax: (202) 690-4631; email: nvpo@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and
Human Services was mandated to establish the National Vaccine Program
to achieve optimal prevention of human infectious diseases through
immunization and to achieve optimal prevention against adverse
reactions to vaccines. The National Vaccine Advisory Committee was
established to provide advice and make recommendations to the Director
of the National Vaccine Program on matters related to the Program's
responsibilities. The Assistant Secretary for Health serves as Director
of the National Vaccine Program.
The topics to be discussed at the NVAC meeting will include
seasonal influenza, implementation of the National Vaccine Plan, and
vaccine safety. The meeting agenda will be posted on the NVAC Web site:
https://www.hhs.gov/nvpo/nvac prior to the meeting.
Public attendance at the meeting is limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the National Vaccine Program Office at the address/phone listed
above at least one week prior to the meeting. Members of the public
will have the opportunity to provide comments at the NVAC meeting,
limited to five minutes per speaker, during the public comment periods
on the agenda. Individuals who would like to submit written statements
should email or fax their comments to the National Vaccine Program
Office at least five business days prior to the meeting.
Dated: January 17, 2012.
Mark Grabowsky,
Deputy Director, National Vaccine Program Office, Alternate Designated
Federal Officer, National Vaccine Advisory Committee.
[FR Doc. 2012-1228 Filed 1-20-12; 8:45 am]
BILLING CODE 4150-44-P